Affidea Onkoterapia sp. z o.o.

Hospital activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2006-12-14
Share capital
9,508,500.00 PLN
Activity description

Affidea Polska operates 43 medical facilities in 31 cities and has provided imaging diagnostics and oncology treatment for more than 20 years. Its services include MRI, CT, PET/CT, pathomorphological and molecular diagnostics, and clinical trials. The company serves patients through NFZ reimbursement and privately, and its network also includes radiotherapy centers and oncology clinics.

Registered address
Plac Europejski 2, 00-844 Warszawa, Poland
Website
Email
Phone
Social media
Electronic delivery address
AE:PL-50098-75637-ECUSR-24

Financials

Revenue history (in m)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 1 of 6 financial statements was filed late (for 2021, 87 days late). All were audited by a statutory auditor.

  • 2025not filed
  • 202415/07/2025
  • 202310/07/2024
  • 202205/07/2023
  • 202110/10/2022
  • 202008/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Industry · Hospital activities89 / 778
Top 11%
Division · Human health activities130 / 7,750
Top 1.7%
Voivodeship · Mazowieckie3,056 / 142,236
Top 2.1%
Country · Poland9,516 / 496,573
Top 1.9%

Results vs industry

Revenue
This companyUSD 29.53mMedianUSD 3.28mAverageUSD 13.52m
Net profit
This companyUSD 7.36mMedianUSD 60.77kAverageUSD 252.28k
Operating costs
This companyUSD 14.89mMedianUSD 2.99mAverageUSD 12.86m
Assets
This companyUSD 187.30mMedianUSD 2.21mAverageUSD 10.96m

Websites

  • achemperek.plAlbert Chemperek – ortopeda w Lublinie
    WordPressApache

National Health Fund (NFZ) contracts

The company has been an NFZ healthcare provider since 2008. In 2026 it is performing 2 contracts with a total value of USD 15.54m. All its contracts were worth USD 120.59m in total.

NFZ contract value by year (in m USD)

Type of careNFZ branchContractsValue in 2026
Inpatient treatmentzachodniopomorskie1USD 14.68m
Outpatient specialist carewielkopolskie1USD 860.05k

NFZ waiting lists

This company's facilities run 8 NFZ waiting lists. Waiting time forecast by NFZ, as of 10.11.2026.

ServiceWaiting time
Radiotherapy department3 days
Positron emission tomography4 days
Oncology services7 days
Isotope therapy12 days
Computed tomography1 mo 3 wk

Authorized Representatives

Agnieszka Szydłowska age 46 – Management Board Member
Tomasz Marek Barski age 57 – Management Board Member
Carole Claudia Ducrest – Management Board Member
Mesut Göral – President of the Management Board
Grzegorz Marcin Wędrychowicz age 52 – Management Board Member

Manner of representation

In the case of a one-person management board, the sole member of the management board has the right to represent the company independently. In the case of a multi-member management board, two members of the management board acting jointly are authorised to represent the company.

Ownership

OwnerSharesShare valueStake
Affidea Cancer Treatment Centres B.v.
190,170$2,568,476.50100%

Beneficial owners

Person

Subsidiaries

NameStake
100%
71%

Capital group

The company belongs to the Affidea Cancer Treatment Centres B.V. (Netherlands) group, which is its direct owner.

Bank accounts

Registered as a VAT taxpayer on 2007-03-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Kliniki Neuroradiochirurgii sp. z o.o.
Mazowiecki Szpital Onkologiczny sp. z o.o.
Tomma Diagnostyka Obrazowa S.A.
Wizja V sp. z o.o.
Telediagnosis sp. z o.o.
Alab Plus sp. z o.o.
Centrum Diagnostyki Medycznej Multi-Med S.A.
Resonica sp. z o.o.
Nukleomed sp. z o.o.
TMS Diagnostyka sp. z o.o.

Change history

DateEvent
2016-08-25Address change
2015-05-11Name change
2015-02-20Share capital increase
2015-02-20Switch to PKD 2007
2011-09-15Address change

FAQ

Last updated: 2026-10-07